Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02681302
Title Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence (CPIT001)
Acronym CPIT001
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Hackensack Meridian Health
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington District of Columbia 20007 United States Details
Hackensack University medical Center Hackensack New Jersey 07601 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field